» Articles » PMID: 12654254

NF-kappaB in Cancer: a Marked Target

Overview
Specialty Oncology
Date 2003 Mar 26
PMID 12654254
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

The imbalance between proliferation and programmed cell death (apoptosis) is one of the critical cellular events that lead to oncogenesis. While there is no doubt that uncontrolled cell proliferation is essential for the development of cancer, deregulation of apoptosis may play an equally important role in this process. Inhibition of apoptosis prevents the death of tumor cells with DNA damage either associated with carcinogenic initiation or cancer therapy. The transcription factor NF-kappaB is a key regulator in oncogenesis. By promoting proliferation and inhibiting apoptosis, NF-kappaB tips the balance between proliferation and apoptosis toward malignant growth in tumor cells.

Citing Articles

Versatile function of NF-ĸB in inflammation and cancer.

Ma Q, Hao S, Hong W, Tergaonkar V, Sethi G, Tian Y Exp Hematol Oncol. 2024; 13(1):68.

PMID: 39014491 PMC: 11251119. DOI: 10.1186/s40164-024-00529-z.


In vitro study on anti-proliferative and anti-cancer activity of picrosides in triple-negative breast cancer.

Soni D, Wahi D, Verma S Med Oncol. 2024; 41(6):143.

PMID: 38717628 DOI: 10.1007/s12032-024-02397-3.


Jozimine A, a Dimeric Naphthylisoquinoline (NIQ) Alkaloid, Shows In Vitro Cytotoxic Effects against Leukemia Cells through NF-κB Inhibition.

Damiescu R, Yucer R, Klauck S, Bringmann G, Efferth T, Dawood M Int J Mol Sci. 2024; 25(6).

PMID: 38542061 PMC: 10970593. DOI: 10.3390/ijms25063087.


Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives.

Tajbakhsh A, Yousefi F, Farahani N, Savardashtaki A, Reiner Z, Jamialahmadi T Curr Med Chem. 2023; 31(36):5898-5917.

PMID: 37497711 DOI: 10.2174/0929867331666230727100123.


Role of APE1/Ref-1 in hydrogen peroxide-induced apoptosis in human renal HK-2 cells.

Kim H, Park J, Jeon B, Choi H, Kim C, Ma S Kidney Res Clin Pract. 2023; 43(2):186-201.

PMID: 37448293 PMC: 11016666. DOI: 10.23876/j.krcp.22.171.